Sign in / Join Now
ETFs & Funds
Alan Robert Ross
CF To 2017: Why PVCT Can Afford To Complete Phase III Trials Without Further Dilution. $
Add a reply...
Latest StockTalks »
people get PVCT breaking news and analysis by email alert.
Get email alerts on PVCT »
Provectus Biopharmaceuticals, Inc.
Get latest price
From other sites
Provectus Biopharmaceuticals To Present At Rodman & Renshaw's 18th Annual Global Investment Conference
at TheStreet (Sep 8, 2016)
Provectus Biopharmaceuticals, Inc. Announces Closing Of Public Offering
at TheStreet (Aug 30, 2016)
Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million
at TheStreet (Aug 25, 2016)
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants
at TheStreet (Aug 24, 2016)
Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs
at TheStreet (Aug 23, 2016)